FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2508367039> ?p ?o ?g. }

• W2508367039 endingPage "62069" @default.
• W2508367039 startingPage "62049" @default.
• W2508367039 abstract "// Xiao-Long Chen 1, 2, * , Xin-Zu Chen 1, 2, * , Yi-Gao Wang 1, 2, * , Du He 3 , Zheng-Hao Lu 1, 2 , Kai Liu 1, 2 , Wei-Han Zhang 1, 2 , Wei Wang 1, 2 , Chang-Chun Li 1, 2 , Lian Xue 1, 2 , Lin-Yong Zhao 1, 2 , Kun Yang 1, 2 , Jian-Ping Liu 3 , Zong-Guang Zhou 1, 4 , Jian-Kun Hu 1, 2 , Xian-Ming Mo 5 1 Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China 2 Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China 3 Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China 4 Institute of Digestive Surgery, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China 5 Laboratory of Stem Cell Biology, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China * These authors have contributed equally to this work Correspondence to: Jian-Kun Hu, email: hujkwch@126.com Keywords: gastric cancer, cancer stem cells, markers, prognosis, nomogram Received: December 22, 2015      Accepted: August 08, 2016      Published: August 19, 2016 ABSTRACT Cancer stem cells (CSCs) are thought as the source of tumor maintaining and many CSCs markers have been identified. Regarding the heterogeneity in gastric cancer (GC), TNM stage is not enough to accurately predict the prognosis. The aim of this study was to investigate the clinical significance of CSCs markers (Lgr5, Oct4, CD133, EpCAM, CD54 and Sox2) and establish a new model based on these markers to accurately predict prognosis of GC. We retrospectively enrolled 377 GC tissues from January 2006 to October 2012 to perform immunohistochemistry (IHC), and 93 pairs of GC tissues and corresponding adjacent normal gastric tissues to perform quantitative PCR (qPCR) from December 2011 to October 2012. The clinicopathological and follow-up characteristics were collected. In IHC, Oct4, CD133 and EpCAM were independently related to tumor progression, while Sox2 were associated with well or moderate differentiation (all p<0.05). Cox regression showed that Oct4-EpCAM was an independently prognostic factor, indicating that double low expression of Oct4-EpCAM group had significantly better prognosis than control group (p=0.035). Regarding qPCR, CD133 was an independent prognostic factor, showing that the prognosis of patients with CD133 high expression was significantly worse than that of patients with CD133 low expression (p<0.001). The prognostic prediction accuracy of nomogram based on Oct4-EpCAM expression in IHC was significantly better than TNM stage alone (p=0.003). Low expressions of Oct4-EpCAM in IHC and CD133 in qPCR were favorable prognostic factors in GC. The nomogram based on Oct4-EpCAM was valuable in prognostic prediction of GC patients." @default.
• W2508367039 created "2016-09-16" @default.
• W2508367039 creator A5000238995 @default.
• W2508367039 creator A5006255404 @default.
• W2508367039 creator A5008337573 @default.
• W2508367039 creator A5026049732 @default.
• W2508367039 creator A5026588980 @default.
• W2508367039 creator A5030303113 @default.
• W2508367039 creator A5035022492 @default.
• W2508367039 creator A5039787929 @default.
• W2508367039 creator A5042115187 @default.
• W2508367039 creator A5044246694 @default.
• W2508367039 creator A5046597133 @default.
• W2508367039 creator A5051363890 @default.
• W2508367039 creator A5056696999 @default.
• W2508367039 creator A5057554882 @default.
• W2508367039 creator A5071799307 @default.
• W2508367039 creator A5073339735 @default.
• W2508367039 date "2016-08-19" @default.
• W2508367039 modified "2023-09-23" @default.
• W2508367039 title "Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study" @default.
• W2508367039 cites W1813089926 @default.
• W2508367039 cites W1884790230 @default.
• W2508367039 cites W1973148453 @default.
• W2508367039 cites W1977007433 @default.
• W2508367039 cites W1977890338 @default.
• W2508367039 cites W1979486580 @default.
• W2508367039 cites W1980128193 @default.
• W2508367039 cites W1981910809 @default.
• W2508367039 cites W1982580620 @default.
• W2508367039 cites W1985464465 @default.
• W2508367039 cites W1987918327 @default.
• W2508367039 cites W1989554701 @default.
• W2508367039 cites W1990877484 @default.
• W2508367039 cites W1992514491 @default.
• W2508367039 cites W1999874799 @default.
• W2508367039 cites W2004624656 @default.
• W2508367039 cites W2009720434 @default.
• W2508367039 cites W2014068893 @default.
• W2508367039 cites W2020469453 @default.
• W2508367039 cites W2057814456 @default.
• W2508367039 cites W2065180481 @default.
• W2508367039 cites W2071261047 @default.
• W2508367039 cites W2077957701 @default.
• W2508367039 cites W2088635881 @default.
• W2508367039 cites W2088645831 @default.
• W2508367039 cites W2100116639 @default.
• W2508367039 cites W2110418441 @default.
• W2508367039 cites W2111954828 @default.
• W2508367039 cites W2114061652 @default.
• W2508367039 cites W2120656656 @default.
• W2508367039 cites W2126547130 @default.
• W2508367039 cites W2126965826 @default.
• W2508367039 cites W2127277715 @default.
• W2508367039 cites W2133902084 @default.
• W2508367039 cites W2142243598 @default.
• W2508367039 cites W2145645875 @default.
• W2508367039 cites W2148560651 @default.
• W2508367039 cites W2156381851 @default.
• W2508367039 cites W2161148715 @default.
• W2508367039 cites W2168574597 @default.
• W2508367039 cites W2183197199 @default.
• W2508367039 cites W2279770316 @default.
• W2508367039 cites W2291038537 @default.
• W2508367039 cites W4246328459 @default.
• W2508367039 doi "https://doi.org/10.18632/oncotarget.11384" @default.
• W2508367039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5308710" @default.
• W2508367039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27557490" @default.
• W2508367039 hasPublicationYear "2016" @default.
• W2508367039 type Work @default.
• W2508367039 sameAs 2508367039 @default.
• W2508367039 citedByCount "28" @default.
• W2508367039 countsByYear W25083670392017 @default.
• W2508367039 countsByYear W25083670392018 @default.
• W2508367039 countsByYear W25083670392019 @default.
• W2508367039 countsByYear W25083670392020 @default.
• W2508367039 countsByYear W25083670392021 @default.
• W2508367039 countsByYear W25083670392022 @default.
• W2508367039 countsByYear W25083670392023 @default.
• W2508367039 crossrefType "journal-article" @default.
• W2508367039 hasAuthorship W2508367039A5000238995 @default.
• W2508367039 hasAuthorship W2508367039A5006255404 @default.
• W2508367039 hasAuthorship W2508367039A5008337573 @default.
• W2508367039 hasAuthorship W2508367039A5026049732 @default.
• W2508367039 hasAuthorship W2508367039A5026588980 @default.
• W2508367039 hasAuthorship W2508367039A5030303113 @default.
• W2508367039 hasAuthorship W2508367039A5035022492 @default.
• W2508367039 hasAuthorship W2508367039A5039787929 @default.
• W2508367039 hasAuthorship W2508367039A5042115187 @default.
• W2508367039 hasAuthorship W2508367039A5044246694 @default.
• W2508367039 hasAuthorship W2508367039A5046597133 @default.
• W2508367039 hasAuthorship W2508367039A5051363890 @default.
• W2508367039 hasAuthorship W2508367039A5056696999 @default.
• W2508367039 hasAuthorship W2508367039A5057554882 @default.
• W2508367039 hasAuthorship W2508367039A5071799307 @default.
• W2508367039 hasAuthorship W2508367039A5073339735 @default.
• W2508367039 hasBestOaLocation W25083670391 @default.
• W2508367039 hasConcept C121608353 @default.

• next